Hospital Pediatrics· 2026Q1
Predictive Performance of Screening Methods for Neonatal Opioid Withdrawal Syndrome
- 0citations
- Q1SCImago
- 2026year
Short summary
Maternal self-disclosure and maternal urine substance screening (USS) combined offer the strongest prediction for neonatal opioid withdrawal syndrome (NOWS) admission (OR, 12.0; AUC, 0.78), outperforming individual methods.
AI-generated from the title and abstract; the full text is not read.
Key points
- Maternal self-disclosure and maternal USS had moderate agreement for opioids (κ = 0.54) and substantial agreement for methadone (κ = 0.80).
- Maternal and neonatal USS showed moderate agreement for opioids (κ = 0.67) and almost perfect agreement for methadone (κ = 0.88).
- Maternal self-disclosure, maternal USS, and neonatal USS predicted NOWS admission with odds ratios (OR) of 9.9, 8.5, and 6.2, respectively.
- Combined maternal history and maternal USS provided the strongest prediction for NOWS admission (OR, 12.0; AUC, 0.78).
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND Routine urine substance screening (USS) in pregnant women for perinatal substance exposure is associated with bias and has limited evidence supporting its use. We evaluated agreement between maternal disclosure, maternal and neonatal USS, and their predictive abilities for neonatal opioid withdrawal syndrome (NOWS) admission. METHODS In this single-center retrospective study, we included pregnant women with gestational substance use and their neonates (February 2018 to December 2022). Agreement between screening tests was assessed using κ. Predictive abilities of the screening were evaluated using logistic regression and area under the receiver operating characteristic curve (AUC). RESULTS We analyzed 1161 paired maternal USS and maternal disclosure of substance use and 907 paired maternal and neonatal USS results. Self-disclosure and maternal USS showed moderate agreement for opioids (κ = 0.54) and substantial agreement for methadone (κ = 0.80). Maternal and neonatal USS demonstrated moderate agreement for opioids (κ = 0.67) and almost perfect agreement for methadone (κ = 0.88). Among 952 infants born during the study period, 277 (29%) were admitted for NOWS and 176 (18.4%) required pharmacotherapy. Odds ratio (OR) for NOWS admission for self-disclosure, maternal USS, and neonatal USS were 9.9, 8.5, and 6.2, and the AUC for the same were 0.75, 0.74, and 0.71, respectively. Combined maternal history and maternal USS provided the strongest prediction (OR, 12.0; AUC, 0.78), whereas combined maternal disclosure, maternal USS, and neonatal USS had an OR of 10.8 and AUC of 0.75. CONCLUSIONS Maternal self-disclosure demonstrated moderate agreement with maternal USS for perinatal opioid exposure. Although combining maternal self-disclosure with maternal USS provided the highest predictive ability for neonatal admission with NOWS, maternal self-disclosure alone remained a reliable predictor.
The authors' abstract, as published at the source. Hospital Pediatrics, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pediatrics, Perinatology and Child Health
Pediatrics, Perinatology and Child HealthMedicine